⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31376856 | 1.00 | — | — | |
| SCHEMBL3667891 | 0.83 | — | — | |
| SCHEMBL16741 | 0.83 | — | — | |
| SCHEMBL4594980 | 0.77 | — | — | |
| SCHEMBL7901642 | 0.77 | — | — | |
| Methane SCHEMBL7938760 | 0.77 | — | — | |
| Hydrazine SCHEMBL4918027 | 0.77 | — | — | |
| Hydroxyamine SCHEMBL272868 | 0.77 | — | — | |
| Phosphine SCHEMBL20595760 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL3442206 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 462 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026089612-A1 | ANTISENSE OLIGONUCLEOTIDES FOR USE IN SKIPPING TRINUCLEOTIDE REPEAT EXPANSIONS | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) | 2026-04-30 | — | — | WO | claimed |
| CN-121574170-A | Phosphorodiamidate morpholino method for purifying oligonucleotides | 杭州诺泰诺和生物医药科技有限公司 | 2026-02-27 | — | — | CN | claimed |
| EP-4686716-A1 | ONE-POT CATALYTIC PROCESS FOR THE PREPARATION OF ALCOHOLS USING METHANOL AS SOURCE FOR CARBON MONOXIDE AND HYDROGEN | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-02-04 | — | — | EP | claimed |
| EP-4049996-B1 | GLYCOSIDE COMPOUND, AMIDITE COMPOUND, AND PRODUCTION METHOD FOR POLYNUCLEOTIDE USING SAID COMPOUNDS | SUMITOMO CHEMICAL CO (JP) | 2026-01-07 | — | — | EP | claimed |
| US-12508320-B2 | Drug conjugate, pharmaceutical composition and method of treating hepatitis | SeeCure Taiwan Co., Ltd. (TW) | 2025-12-30 | — | — | US | claimed |
| US-12509481-B2 | Glycoside compound, amidite compound, and production method for polynucleotide using said compounds | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2025-12-30 | — | — | US | claimed |
| US-20250388619-A1 | VERSATILE SYNTHETIC ROUTE FOR NEUTRAL MORPHOLINO OLIGONUCLEOTIDES WITH PHOSPHORYL GUANIDINIUM (PG) BACKBONE | BIO SYNTHESIS INC (US) | 2025-12-25 | — | — | US | claimed |
| US-20250346623-A1 | VERSATILE SYNTHETIC ROUTE FOR NEUTRAL MORPHOLINO OLIGONUCLEOTIDES WITH PHOSPHORYL GUANIDINIUM (PG) BACKBONE | BIO SYNTHESIS INC (US) | 2025-11-13 | — | — | US | claimed |
| US-20250215432-A1 | BRANCHED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS | NOVARTIS AG (CH) | 2025-07-03 | — | — | US | claimed |
| CN-114615998-B | Conjugate and use thereof | 牛津大学科技创新有限公司 | 2025-05-23 | — | — | CN | claimed |
| US-11230565-B2 | Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2022-01-25 | — | — | US | claimed |
| CN-109134541-A | Long-chain biological element marker and its preparation method and application | 伯科生物医学科技（北京）有限公司 | 2019-01-04 | — | — | CN | claimed |
| CN-106132973-B | The preparation of the phosphorous acid diamide of purifying | 罗地亚经营管理公司 | 2018-10-16 | — | — | CN | claimed |
| CN-106795200-A | Galnac phosphoramidites, nucleic acid conjugates thereof, and uses thereof | 豪夫迈·罗氏有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106518910-A | Method for preparing dialkyl chlorophosphate reagent through trimethylpyridine-phosphamide | 江苏海阔生物医药有限公司 | 2017-03-22 | — | — | CN | claimed |
| CN-106132973-A | The preparation of the phosphorous acid diamide of purification | 罗地亚经营管理公司 | 2016-11-16 | — | — | CN | claimed |
| EP-1888748-B1 | STABLE AND SELECTIVE FORMATION OF HOOGSTEEN-TYPE TRIPLEXES AND DUPLEXES USING TWISTED INTERCALATING NUCLEIC ACIDS (TINA) AND PROCESS FOR THE PREPARATION OF TINA | TINA HOLDING APS (DK) | 2013-08-28 | — | — | EP | claimed |
| CN-101652378-A | 2-5A derivatives and their use as anticancer, antiviral and antiparasitic agents | ALIOS BIOPHARMA INC US | 2010-02-17 | — | — | CN | claimed |
| US-5567841-A | ANTICHOLESTEROL AGENT | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-10-22 | — | — | US | claimed |
| EP-0595635-A1 | Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors | E.R. Squibb & Sons, Inc. (US) | 1994-05-04 | — | — | EP | claimed |